RASSF1 and invasive breast carcinoma: RASSF1α promoter methylation has been used as a biomarker for detecting field cancerization in non-invasive breast cancer and as a prognostic factor in invasive breast cancer (Spitzwieser et al., 2015[10]; Shakeri et al., 2016[8]).